The IQT Podcast

IQT Explains: Space Origins & The Startup Ecosystem

This episode kicks off a three-part space series featuring some of IQT's domain experts to explore IQT’s space efforts through the years and how they've helped enhance national security. In this first episode, host Vishal Sandesara is joined by IQT's Dave LoBosco and Tom Gillespie to expand on the origins of the space startup ecosystem and the history of IQT's space efforts that helped shape the current framework used today. 

IQT Explains: Advanced Materials Innovation

Materials innovation touches almost every aspect of our daily lives, and the materials we rely on are advancing at an exponential pace. On this week's IQT Explores episode, Vishal Sandesara is joined by Victoria Chernow and Steve Taub to discuss the history of advanced materials and how they are developed today, the investing landscape, and what the future may hold for this ever-evolving industry.

IQT Explains: Digital Health Tools to Support National Security

As health threats continuously evolve in the 21st century, so too has digital health technology. This podcast offers insights from IQT's Dan Hanfling and Eugene Chiu about how utilizing a wide array of digital health tools can create a better information supply chain required for disaster response at the regional, state, and national level.

The Intersection: Technology, Economic Growth, & National Security

This week on The Intersection, IQT's Steve Bowsher talks with Eli Dourado, a Senior Research Fellow at the Center for Growth and Opportunity at Utah State University, about the future of cutting-edge bio, energy, and space technologies and their commercial and national security implications.

The Intersection: Transitioning from government to startups

This week’s episode of The Intersection features a conversation between Steve Bowsher and Dr. Ellison Anne Williams, CEO and Founder of Enveil. Tune in to hear their discussion on the challenges and opportunities in transitioning from a career with the federal government to starting a company from scratch.

The Intersection: The Future of Disruptive Innovations

On this episode of The Intersection series, Steve Bowsher speaks with Chris Brose, Chief Strategy Officer of Anduril and author of “The Kill Chain.” Listen in as they discuss the future of disruptive innovations and the relationship between government and emerging technologies.

The Intersection: Tech Entrepreneurs & The Government Market

This week in The Intersection, listen in as Steve Bowsher talks with Mike Appelbaum, two-time CEO of In-Q-Tel portfolio companies, to discuss why startups should consider the government market. 

The Intersection (debut): Startups and Working with the Government

The debut of The Intersection: Mission Investing for National Security. Hosted by IQT President Steve Bowsher, the inaugural pod with TJ Rylander from Next47 features insights about sourcing and supporting startups, a company's makeup to work with the government market, and more.

Synthetic Biology for Enhanced Biosecurity: New Genetic Circuits and Switches

As synthetic biology continues to evolve, the ability to control engineered organisms is more important now than ever. In this episode, B.Next's Dr. Kevin O'Connell is joined by Gabriel Lopez, the Co-founder and CEO of Synvivia, a company focused on building protein switches to control the behavior of genetically engineered organisms. Learn more about these protein switches, their commercial applications, how they can enhance biosecurity, and more. 

Learn more at synvivia.com

Getting Back to Work and School: Enhancing Access to COVID-19 Testing

In the era of COVID-19, how do we create safe environments for people to return to work, school, and their daily lives? B.Next's Dr. Kevin O'Connell is joined by Troy Moore, Chief Scientific Officer and Founder at Kailos Genetics, an In-Q-Tel portfolio company providing cost-effective solutions that make genetic screening accessible to everyone. Listen in as the two explore the importance and impact of testing, genetic sequencing, the company's capture and enrichment methodology adapted to work with the COVID-19 virus, and more.